132 related articles for article (PubMed ID: 10935205)
1. QSAR and molecular graphics analysis of N2-phenylguanines as inhibitors of herpes simplex virus thymidine kinases.
Gaudio AC; Richards WG; Takahata Y
J Mol Graph Model; 2000 Feb; 18(1):33-41. PubMed ID: 10935205
[TBL] [Abstract][Full Text] [Related]
2. Prediction of the binding mode of N2-phenylguanine derivative inhibitors to herpes simplex virus type 1 thymidine kinase.
Gaudio AC; Takahata Y; Richards WG
J Comput Aided Mol Des; 1998 Jan; 12(1):15-25. PubMed ID: 9570086
[TBL] [Abstract][Full Text] [Related]
3. Computer-aided active-site-directed modeling of the herpes simplex virus 1 and human thymidine kinase.
Folkers G; Trumpp-Kallmeyer S; Gutbrod O; Krickl S; Fetzer J; Keil GM
J Comput Aided Mol Des; 1991 Oct; 5(5):385-404. PubMed ID: 1663155
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationships of N2-substituted guanines as inhibitors of HSV1 and HSV2 thymidine kinases.
Hildebrand C; Sandoli D; Focher F; Gambino J; Ciarrocchi G; Spadari S; Wright G
J Med Chem; 1990 Jan; 33(1):203-6. PubMed ID: 2153203
[TBL] [Abstract][Full Text] [Related]
5. Quantitative structure-activity relationships of N2-phenylguanines as inhibitors of herpes simplex virus thymidine kinases.
Gambino J; Focher F; Hildebrand C; Maga G; Noonan T; Spadari S; Wright G
J Med Chem; 1992 Aug; 35(16):2979-83. PubMed ID: 1323680
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, properties, and pharmacokinetic studies of N2-phenylguanine derivatives as inhibitors of herpes simplex virus thymidine kinases.
Xu H; Maga G; Focher F; Smith ER; Spadari S; Gambino J; Wright GE
J Med Chem; 1995 Jan; 38(1):49-57. PubMed ID: 7837239
[TBL] [Abstract][Full Text] [Related]
7. Testing the sensitivities of noncognate inhibitors to varicella zoster virus thymidine kinase: implications for postherpetic neuralgia therapy with existing agents.
Yang L; Mo X; Yang H; Dai H; Tan F
J Mol Model; 2014 Jul; 20(7):2321. PubMed ID: 24961898
[TBL] [Abstract][Full Text] [Related]
8. Kinetics and crystal structure of the wild-type and the engineered Y101F mutant of Herpes simplex virus type 1 thymidine kinase interacting with (North)-methanocarba-thymidine.
Prota A; Vogt J; Pilger B; Perozzo R; Wurth C; Marquez VE; Russ P; Schulz GE; Folkers G; Scapozza L
Biochemistry; 2000 Aug; 39(31):9597-603. PubMed ID: 10924157
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of herpes simplex virus thymidine kinases by 2-phenylamino-6-oxopurines and related compounds: structure-activity relationships and antiherpetic activity in vivo.
Manikowski A; Verri A; Lossani A; Gebhardt BM; Gambino J; Focher F; Spadari S; Wright GE
J Med Chem; 2005 Jun; 48(11):3919-29. PubMed ID: 15916444
[TBL] [Abstract][Full Text] [Related]
10. Kinetic studies with N2-phenylguanines and with L-thymidine indicate that herpes simplex virus type-1 thymidine kinase and thymidylate kinase share a common active site.
Maga G; Focher F; Wright GE; Capobianco M; Garbesi A; Bendiscioli A; Spadari S
Biochem J; 1994 Aug; 302 ( Pt 1)(Pt 1):279-82. PubMed ID: 8068016
[TBL] [Abstract][Full Text] [Related]
11. Molecular-genetic PET imaging using an HSV1-tk mutant reporter gene with enhanced specificity to acycloguanosine nucleoside analogs.
Najjar AM; Nishii R; Maxwell DS; Volgin A; Mukhopadhyay U; Bornmann WG; Tong W; Alauddin M; Gelovani JG
J Nucl Med; 2009 Mar; 50(3):409-16. PubMed ID: 19223410
[TBL] [Abstract][Full Text] [Related]
12. Drug resistance of herpes simplex virus type 1--structural considerations at the molecular level of the thymidine kinase.
Kussmann-Gerber S; Kuonen O; Folkers G; Pilger BD; Scapozza L
Eur J Biochem; 1998 Jul; 255(2):472-81. PubMed ID: 9716390
[TBL] [Abstract][Full Text] [Related]
13. Structural basis for the dual thymidine and thymidylate kinase activity of herpes thymidine kinases.
Gardberg A; Shuvalova L; Monnerjahn C; Konrad M; Lavie A
Structure; 2003 Oct; 11(10):1265-77. PubMed ID: 14527394
[TBL] [Abstract][Full Text] [Related]
14. N1-substituted thymine derivatives as mitochondrial thymidine kinase (TK-2) inhibitors.
Hernandez AI; Familiar O; Negri A; Rodríguez-Barrios F; Gago F; Karlsson A; Camarasa MJ; Balzarini J; Pérez-Pérez MJ
J Med Chem; 2006 Dec; 49(26):7766-73. PubMed ID: 17181158
[TBL] [Abstract][Full Text] [Related]
15. Integrated homology modelling and X-ray study of herpes simplex virus I thymidine kinase: a case study.
Folkers G; Alber F; Amrhein I; Behrends H; Bohner T; Gerber S; Kuonen O; Scapozza L
J Recept Signal Transduct Res; 1997; 17(1-3):475-94. PubMed ID: 9029509
[TBL] [Abstract][Full Text] [Related]
16. A new nucleoside analogue with potent activity against mutant sr39 herpes simplex virus-1 (HSV-1) thymidine kinase (TK).
Sundaram GS; Harpstrite SE; Kao JL; Collins SD; Sharma V
Org Lett; 2012 Jul; 14(14):3568-71. PubMed ID: 22765027
[TBL] [Abstract][Full Text] [Related]
17. Biochemical and structural characterization of (South)-methanocarbathymidine that specifically inhibits growth of herpes simplex virus type 1 thymidine kinase-transduced osteosarcoma cells.
Schelling P; Claus MT; Johner R; Marquez VE; Schulz GE; Scapozza L
J Biol Chem; 2004 Jul; 279(31):32832-8. PubMed ID: 15163659
[TBL] [Abstract][Full Text] [Related]
18. QSAR of N2-phenylguanidines as inhibitors of herpes simplex virus-1 thymidine kinase.
Hadjipavlou-Litina D
Pharmazie; 1995 Dec; 50(12):796-8. PubMed ID: 8584555
[TBL] [Abstract][Full Text] [Related]
19. Quantitative Structure-Activity Relationship in the Series of 5-Ethyluridine, N2-Guanine, and 6-Oxopurine Derivatives with Pronounced Anti-Herpetic Activity.
Khairullina V; Martynova Y
Molecules; 2023 Nov; 28(23):. PubMed ID: 38067446
[TBL] [Abstract][Full Text] [Related]
20. The A167Y mutation converts the herpes simplex virus type 1 thymidine kinase into a guanosine analogue kinase.
Balzarini J; Liekens S; Esnouf R; De Clercq E
Biochemistry; 2002 May; 41(20):6517-24. PubMed ID: 12009916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
